Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Intestinal Parasitic Infections in Internationally Adopted Children: A 10-Year Retrospective Study.

Buonsenso D, Graffeo R, Scarlato L, Acampora A, Grotti G, Scarlato L, Pata D, Colonna AT, Salerno G, Colussi L, Masucci L, Valentini P.

Pediatr Infect Dis J. 2019 Aug 23. doi: 10.1097/INF.0000000000002399. [Epub ahead of print]

PMID:
31460872
2.

Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA).

Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Yu JB, Chiang V, Jain S, Gaspar LE, Myrehaug S, Sahgal A, Braunstein S, Sneed P, Cameron B, Attia A, Molitoris J, Wu CC, Wang TJC, Lockney NA, Beal K, Parkhurst J, Buatti JM, Shanley R, Lou E, Tandberg DD, Kirkpatrick JP, Shi D, Shih HA, Chuong M, Saito H, Aoyama H, Masucci L, Roberge D, Mehta MP.

Clin Transl Radiat Oncol. 2019 Jun 27;18:39-45. doi: 10.1016/j.ctro.2019.06.007. eCollection 2019 Sep.

3.

Diagnostic Reliability of Leptomeningeal Disease Using Magnetic Resonance Imaging.

Harris P, Diouf A, Guilbert F, Ameur F, Letourneau-Guillon L, Ménard C, Masucci L, Bélair M, Roberge D.

Cureus. 2019 Apr 9;11(4):e4416. doi: 10.7759/cureus.4416.

4.

Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis.

Petito V, Graziani C, Lopetuso LR, Fossati M, Battaglia A, Arena V, Scannone D, Quaranta G, Quagliariello A, Del Chierico F, Putignani L, Masucci L, Sanguinetti M, Sgambato A, Gasbarrini A, Scaldaferri F.

World J Gastroenterol. 2019 Mar 28;25(12):1465-1477. doi: 10.3748/wjg.v25.i12.1465.

5.

Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?

Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Yu J, Chiang V, Jain S, Gaspar LE, Myrehaug S, Sahgal A, Braunstein S, Sneed P, Cameron B, Attia A, Molitoris J, Wu CC, Wang TJC, Lockney N, Beal K, Parkhurst J, Buatti JM, Shanley R, Lou E, Tandberg DD, Kirkpatrick JP, Shi D, Shih HA, Chuong M, Saito H, Aoyama H, Masucci L, Roberge D, Mehta MP.

Transl Res. 2019 Jun;208:63-72. doi: 10.1016/j.trsl.2019.02.011. Epub 2019 Feb 27.

PMID:
30885538
6.

Universal screening of newborns for biliary atresia: Cost-effectiveness of alternative strategies.

Masucci L, Schreiber RA, Kaczorowski J, Collet JP, Bryan S.

J Med Screen. 2019 Sep;26(3):113-119. doi: 10.1177/0969141319832039. Epub 2019 Mar 14. No abstract available.

PMID:
30871409
7.

Clostridium difficile: trend in an Italian Tertiary Care Hospital during fifteen years, 2002-2016.

Masucci L, Nicolotti N, Graffeo R, Tamburrano A, Archibusacci CM, Nagel D, Quaranta G, Eisendle K, Primus S, Romano L, Mazzella P, Posteraro B, Cammarota G, Sanguinetti M.

Minerva Med. 2019 Apr;110(2):168-171. doi: 10.23736/S0026-4806.18.05740-3. No abstract available.

PMID:
30821431
8.

Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center.

de Belvis AG, Barbara A, Giubbini G, Traglia S, Angioletti C, Ianiro G, Masucci L, Sanguinetti M, Laurenti P, Cambieri A, Gasbarrini A, Ricciardi W, Cammarota G.

Int J Infect Dis. 2019 Mar;80:105-110. doi: 10.1016/j.ijid.2019.01.025. Epub 2019 Jan 22.

9.

Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool.

Sperduto PW, Deegan BJ, Li J, Jethwa KR, Brown PD, Lockney N, Beal K, Rana NG, Attia A, Tseng CL, Sahgal A, Shanley R, Sperduto WA, Lou E, Zahra A, Buatti JM, Yu JB, Chiang V, Molitoris JK, Masucci L, Roberge D, Shi DD, Shih HA, Olson A, Kirkpatrick JP, Braunstein S, Sneed P, Mehta MP.

Neuro Oncol. 2018 Nov 12;20(12):1652-1660. doi: 10.1093/neuonc/noy099.

PMID:
30418657
10.

Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats.

Posteraro B, Paroni Sterbini F, Petito V, Rocca S, Cubeddu T, Graziani C, Arena V, Vassallo GA, Mosoni C, Lopetuso L, Lorrai I, Maccioni P, Masucci L, Martini C, Gasbarrini A, Sanguinetti M, Colombo G, Addolorato G.

Alcohol Clin Exp Res. 2018 Dec;42(12):2313-2325. doi: 10.1111/acer.13900. Epub 2018 Oct 29.

PMID:
30320890
11.

Anterolateral Cervical Kyphoplasty for Metastatic Cervical Spine Lesions.

Sebaaly A, Najjar A, Wang Z, Boubez G, Masucci L, Shedid D.

Asian Spine J. 2018 Oct;12(5):823-829. doi: 10.31616/asj.2018.12.5.823. Epub 2018 Sep 10.

12.

Pharmacotherapy vs surgery as initial therapy for patients with moderate-to-severe benign prostate hyperplasia: a cost-effectiveness analysis.

Erman A, Masucci L, Krahn MD, Elterman DS.

BJU Int. 2018 Nov;122(5):879-888. doi: 10.1111/bju.14520. Epub 2018 Sep 11.

PMID:
30113127
13.

Economic evaluation of smoking cessation in Ontario's regional cancer programs.

Djalalov S, Masucci L, Isaranuwatchai W, Evans W, Peter A, Truscott R, Cameron E, Mittmann N, Rabeneck L, Chan K, Hoch JS.

Cancer Med. 2018 Sep;7(9):4765-4772. doi: 10.1002/cam4.1495. Epub 2018 Jul 17.

14.

Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases.

Sperduto PW, Deegan BJ, Li J, Jethwa KR, Brown PD, Lockney N, Beal K, Rana NG, Attia A, Tseng CL, Sahgal A, Shanley R, Sperduto WA, Lou E, Zahra A, Buatti JM, Yu JB, Chiang V, Molitoris JK, Masucci L, Roberge D, Shi DD, Shih HA, Olson A, Kirkpatrick JP, Braunstein S, Sneed P, Mehta MP.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):845-853. doi: 10.1016/j.ijrobp.2018.04.006. Epub 2018 Apr 12.

PMID:
29976497
15.

Cost analysis of Greenlight photoselective vaporization of the prostate compared to transurethral resection of the prostate for benign prostatic hyperplasia.

Masucci L, Erman A, Krahn MD, Elterman D.

Can Urol Assoc J. 2018 Jun 19. doi: 10.5489/cuaj.5267. [Epub ahead of print]

16.

Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions.

Ianiro G, Masucci L, Quaranta G, Simonelli C, Lopetuso LR, Sanguinetti M, Gasbarrini A, Cammarota G.

Aliment Pharmacol Ther. 2018 Jul;48(2):152-159. doi: 10.1111/apt.14816. Epub 2018 May 30.

PMID:
29851107
17.

Pyroelectric Effect Enables Simple and Rapid Evaluation of Biofilm Formation.

Gennari O, Marchesano V, Rega R, Mecozzi L, Nazzaro F, Fratianni F, Coppola R, Masucci L, Mazzon E, Bramanti A, Ferraro P, Grilli S.

ACS Appl Mater Interfaces. 2018 May 9;10(18):15467-15476. doi: 10.1021/acsami.8b02815. Epub 2018 Apr 27.

PMID:
29676891
18.

Province-wide Biliary Atresia Home Screening Program in British Columbia: Evaluation of First 2 Years.

Woolfson JP, Schreiber RA, Butler AE, MacFarlane J, Kaczorowski J, Masucci L, Bryan S, Collet JP.

J Pediatr Gastroenterol Nutr. 2018 Jun;66(6):845-849. doi: 10.1097/MPG.0000000000001950.

PMID:
29570556
19.

Actoxumab + bezlotoxumab combination: what promise for Clostridium difficile treatment?

Posteraro B, Pea F, Masucci L, Posteraro P, Sanguinetti M.

Expert Opin Biol Ther. 2018 Apr;18(4):469-476. doi: 10.1080/14712598.2018.1452908. Epub 2018 Mar 15. Review.

PMID:
29534621
20.

Procarbazine, lomustine and vincristine toxicity in low-grade gliomas.

Jutras G, Bélanger K, Letarte N, Adam JP, Roberge D, Lemieux B, Lemieux-Blanchard É, Masucci L, Ménard C, Bahary JP, Moumdjian R, Berthelet F, Florescu M.

Curr Oncol. 2018 Feb;25(1):e33-e39. doi: 10.3747/co.25.3680. Epub 2018 Feb 28.

21.

Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR).

Masucci L, Beca J, Sabharwal M, Hoch JS.

Pharmacoecon Open. 2017 Dec;1(4):255-263. doi: 10.1007/s41669-017-0018-3.

22.

Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA).

Sperduto PW, Jiang W, Brown PD, Braunstein S, Sneed P, Wattson DA, Shih HA, Bangdiwala A, Shanley R, Lockney NA, Beal K, Lou E, Amatruda T, Sperduto WA, Kirkpatrick JP, Yeh N, Gaspar LE, Molitoris JK, Masucci L, Roberge D, Yu J, Chiang V, Mehta M.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):812-816. doi: 10.1016/j.ijrobp.2017.06.2454.

PMID:
29063850
23.

Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists.

van Katwyk S, Jin YP, Trope GE, Buys Y, Masucci L, Wedge R, Flanagan J, Brent MH, El-Defrawy S, Tu HA, Thavorn K.

Value Health. 2017 Sep;20(8):1034-1040. doi: 10.1016/j.jval.2017.04.015. Epub 2017 Jun 1.

24.

The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases.

Sperduto PW, Jiang W, Brown PD, Braunstein S, Sneed P, Wattson DA, Shih HA, Bangdiwala A, Shanley R, Lockney NA, Beal K, Lou E, Amatruda T, Sperduto WA, Kirkpatrick JP, Yeh N, Gaspar LE, Molitoris JK, Masucci L, Roberge D, Yu J, Chiang V, Mehta M.

Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1069-1077. doi: 10.1016/j.ijrobp.2017.03.030. Epub 2017 Mar 29.

PMID:
28721890
25.

Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders.

Lopetuso LR, Petito V, Graziani C, Schiavoni E, Paroni Sterbini F, Poscia A, Gaetani E, Franceschi F, Cammarota G, Sanguinetti M, Masucci L, Scaldaferri F, Gasbarrini A.

Dig Dis. 2018;36(1):56-65. doi: 10.1159/000477205. Epub 2017 Jul 7.

PMID:
28683448
26.

Limitations of Personalized Medicine and Gene Assays for Breast Cancer.

Tiberi D, Masucci L, Shedid D, Roy I, Vu T, Patocskai E, Robidoux A, Wong P.

Cureus. 2017 Mar 17;9(3):e1100. doi: 10.7759/cureus.1100.

27.

Efficiency of Crizotinib on an ALK-Positive Inflammatory Myofibroblastic Tumor of the Central Nervous System: A Case Report.

Chennouf A, Arslanian E, Roberge D, Berthelet F, Bojanowski M, Bahary JP, Masucci L, Belanger K, Florescu M, Wong P.

Cureus. 2017 Mar 2;9(3):e1068. doi: 10.7759/cureus.1068.

28.

The impacts of mid-treatment CBCT-guided patient repositioning on target coverage during lung VMAT.

Mathieu D, Campeau MP, Bedwani S, Roberge D, Doucet R, Zerouali K, Bahig H, Vu T, Lambert L, Masucci L, Filion E.

J Med Imaging Radiat Oncol. 2017 Aug;61(4):543-549. doi: 10.1111/1754-9485.12591. Epub 2017 Feb 7.

PMID:
28168813
29.

European consensus conference on faecal microbiota transplantation in clinical practice.

Cammarota G, Ianiro G, Tilg H, Rajilić-Stojanović M, Kump P, Satokari R, Sokol H, Arkkila P, Pintus C, Hart A, Segal J, Aloi M, Masucci L, Molinaro A, Scaldaferri F, Gasbarrini G, Lopez-Sanroman A, Link A, de Groot P, de Vos WM, Högenauer C, Malfertheiner P, Mattila E, Milosavljević T, Nieuwdorp M, Sanguinetti M, Simren M, Gasbarrini A; European FMT Working Group.

Gut. 2017 Apr;66(4):569-580. doi: 10.1136/gutjnl-2016-313017. Epub 2017 Jan 13.

30.

Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study.

Ianiro G, Valerio L, Masucci L, Pecere S, Bibbò S, Quaranta G, Posteraro B, Currò D, Sanguinetti M, Gasbarrini A, Cammarota G.

Clin Microbiol Infect. 2017 May;23(5):337.e1-337.e3. doi: 10.1016/j.cmi.2016.12.025. Epub 2017 Jan 3.

31.

The role of diet on gut microbiota composition.

Bibbò S, Ianiro G, Giorgio V, Scaldaferri F, Masucci L, Gasbarrini A, Cammarota G.

Eur Rev Med Pharmacol Sci. 2016 Nov;20(22):4742-4749. Review.

32.

A Study of Pseudoprogression After Spine Stereotactic Body Radiation Therapy.

Bahig H, Simard D, Létourneau L, Wong P, Roberge D, Filion E, Donath D, Sahgal A, Masucci L.

Int J Radiat Oncol Biol Phys. 2016 Nov 15;96(4):848-856. doi: 10.1016/j.ijrobp.2016.07.034. Epub 2016 Jul 30.

PMID:
27788956
33.

Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients.

Paroni Sterbini F, Palladini A, Masucci L, Cannistraci CV, Pastorino R, Ianiro G, Bugli F, Martini C, Ricciardi W, Gasbarrini A, Sanguinetti M, Cammarota G, Posteraro B.

Appl Environ Microbiol. 2016 Oct 27;82(22):6633-6644. Print 2016 Nov 15.

34.

In vitro effect of clarithromycin and alginate lyase against helicobacter pylori biofilm.

Bugli F, Palmieri V, Torelli R, Papi M, De Spirito M, Cacaci M, Galgano S, Masucci L, Paroni Sterbini F, Vella A, Graffeo R, Posteraro B, Sanguinetti M.

Biotechnol Prog. 2016 Nov;32(6):1584-1591. doi: 10.1002/btpr.2339. Epub 2016 Sep 8.

PMID:
27535356
35.

Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis.

Scaldaferri F, Pecere S, Petito V, Zambrano D, Fiore L, Lopetuso LR, Schiavoni E, Bruno G, Gerardi V, Laterza L, Pizzoferrato M, Ianiro G, Stojanovic J, Poscia A, Papa A, Paroni Sterbini F, Sanguinetti M, Masucci L, Cammarota G, Gasbarrini A.

Transplant Proc. 2016 Mar;48(2):402-7. doi: 10.1016/j.transproceed.2015.12.040. Review. Erratum in: Transplant Proc. 2018 Jan - Feb;50(1):305.

PMID:
27109966
36.

Assessment of function and quality of life in a phase II multi-institutional clinical trial of fractionated simultaneous in-field boost radiotherapy for patients with 1-3 metastases.

Bauman G, Yartsev S, Roberge D, MacRae R, Roa W, Panet-Raymond V, Masucci L, Yaremko B, D'Souza D, Palma D, Sexton T, Yu E, Pantarotto JR, Ahmad B, Fisher B, Dar AR, Lambert C, Pond G, Stitt L, Tay KY, Rodrigues G.

J Neurooncol. 2016 Jul;128(3):431-6. doi: 10.1007/s11060-016-2128-7. Epub 2016 Apr 15.

PMID:
27084705
37.

Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases.

Cammarota G, Pecere S, Ianiro G, Masucci L, Currò D.

Dig Dis. 2016;34(3):279-85. doi: 10.1159/000443362. Epub 2016 Mar 30. Review.

PMID:
27027524
38.

The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin.

Ponziani FR, Scaldaferri F, Petito V, Paroni Sterbini F, Pecere S, Lopetuso LR, Palladini A, Gerardi V, Masucci L, Pompili M, Cammarota G, Sanguinetti M, Gasbarrini A.

Dig Dis. 2016;34(3):269-78. doi: 10.1159/000443361. Epub 2016 Mar 30. Review.

PMID:
27027301
39.

Cost-effectiveness of a fracture liaison service--a real-world evaluation after 6 years of service provision.

Yong JH, Masucci L, Hoch JS, Sujic R, Beaton D.

Osteoporos Int. 2016 Jan;27(1):231-40. doi: 10.1007/s00198-015-3280-1. Epub 2015 Aug 15.

PMID:
26275439
40.

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection.

Cammarota G, Masucci L, Ianiro G, Bibbò S, Dinoi G, Costamagna G, Sanguinetti M, Gasbarrini A.

Aliment Pharmacol Ther. 2015 May;41(9):835-43. doi: 10.1111/apt.13144. Epub 2015 Mar 1.

41.

Harmonization of HTA--based reimbursement and regulatory approval activities: a qualitative study.

Tsoi B, O'Reilly D, Masucci L, Drummond M, Goeree R.

J Popul Ther Clin Pharmacol. 2015;22(1):e78-89. Epub 2015 Feb 21.

PMID:
25715384
42.

Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection.

Russo A, Falcone M, Fantoni M, Murri R, Masucci L, Carfagna P, Ghezzi MC, Posteraro B, Sanguinetti M, Venditti M.

Clin Microbiol Infect. 2015 May;21(5):493.e1-4. doi: 10.1016/j.cmi.2014.12.024. Epub 2015 Jan 14.

43.

Home-based screening for biliary atresia using infant stool colour cards: a large-scale prospective cohort study and cost-effectiveness analysis.

Schreiber RA, Masucci L, Kaczorowski J, Collet JP, Lutley P, Espinosa V, Bryan S.

J Med Screen. 2014 Sep;21(3):126-32. doi: 10.1177/0969141314542115. Epub 2014 Jul 9.

PMID:
25009198
44.

Entamoeba dispar: A Rare Case of Enteritis in a Patient Living in a Nonendemic Area.

Graffeo R, Archibusacci CM, Soldini S, Romano L, Masucci L.

Case Rep Gastrointest Med. 2014;2014:498058. doi: 10.1155/2014/498058. Epub 2014 Feb 13.

45.

Culture-guided treatment approach for Helicobacter pylori infection: review of the literature.

Cammarota G, Ianiro G, Bibbò S, Di Rienzo TA, Masucci L, Sanguinetti M, Gasbarrini A.

World J Gastroenterol. 2014 May 14;20(18):5205-11. doi: 10.3748/wjg.v20.i18.5205. Review.

46.

Faecal transplantation for Clostridium difficile infection. Three cases treated in Italy.

Cammarota G, Ianiro G, Gasbarrini A, Masucci L, Sanguinetti M.

Dig Liver Dis. 2014 May;46(5):475. doi: 10.1016/j.dld.2013.12.011. Epub 2014 Jan 20. No abstract available.

PMID:
24457126
47.

Vitamin B12 intramuscular injections versus oral supplements: a budget impact analysis.

Masucci L, Goeree R.

Ont Health Technol Assess Ser. 2013 Nov 1;13(24):1-24. eCollection 2013. Review.

48.

Cost-effectiveness of the carbon-13 urea breath test for the detection of Helicobacter pylori: an economic analysis.

Masucci L, Blackhouse G, Goeree R.

Ont Health Technol Assess Ser. 2013 Oct 1;13(20):1-28. eCollection 2013. Review.

49.

Surgical resection of epidural disease improves local control following postoperative spine stereotactic body radiotherapy.

Al-Omair A, Masucci L, Masson-Cote L, Campbell M, Atenafu EG, Parent A, Letourneau D, Yu E, Rampersaud R, Massicotte E, Lewis S, Yee A, Thibault I, Fehlings MG, Sahgal A.

Neuro Oncol. 2013 Oct;15(10):1413-9. doi: 10.1093/neuonc/not101.

50.

Harmonization of reimbursement and regulatory approval processes: a systematic review of international experiences.

Tsoi B, Masucci L, Campbell K, Drummond M, O'Reilly D, Goeree R.

Expert Rev Pharmacoecon Outcomes Res. 2013 Aug;13(4):497-511. doi: 10.1586/14737167.2013.814962. Review.

PMID:
23977976

Supplemental Content

Loading ...
Support Center